Heart & Rhythm Institute Of Trinity And Avertix Announce Partnership To Improve Cardiac Care And Patient Monitoring
Portfolio Pulse from Benzinga Newsdesk
Heart & Rhythm Institute of Trinity has partnered with Avertix to improve cardiac care and patient monitoring. The Avertix Guardian System, the first FDA approved implantable heart attack warning system, is now available at the Heart & Rhythm Institute of Trinity. Dr. Luis R. Annoni-Suau, MD, FACC and Dr. Carlos J. Bayron have successfully performed the first two Guardian implants.
August 16, 2023 | 12:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The partnership between Heart & Rhythm Institute of Trinity and Avertix could potentially increase the demand for BIOS's products and services.
The partnership with Avertix, which involves the use of the FDA approved Avertix Guardian System, could potentially increase the demand for BIOS's products and services. This could have a positive impact on the company's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50